Dr. Claudia Gidea was appointed medical director of heart transplant, mechanical circulatory support and advanced heart failure at Newark Beth Israel Medical Center, according to a recent announcement.
An accomplished clinician, Gidea brings more than 20 years of research, innovation and clinical expertise to the Advanced Heart Failure Treatment and Transplant team at Newark Beth Israel Medical Center. She has published extensively in the field of heart transplantation and has been a regional leader in establishing programs to increase the availability of organs for donation and allow patients to get transplanted sooner.
“Dr. Gidea has a proven track record of delivering excellent care to our advanced heart failure patients, and we are excited to welcome her back to the team,” Dr. Sergio Waxman, director of cardiology, Newark Beth Israel Medical Center, said.
“Our Advanced Heart Failure Treatment and Transplant team is at the forefront of delivering comprehensive care and advanced treatment options to our heart failure patients. Dr. Gidea is a seasoned professional who brings a wealth of experience to this expanded role and we are proud to welcome her back to Newark Beth Israel Medical Center,” Darrell Terry Sr., CEO and president of Newark Beth Israel Medical Center and Children’s Hospital of New Jersey, said.
Gidea is returning to Newark Beth Israel Medical Center after serving as medical director of the Heart Transplant and LVAD Program at Icahn School of Medicine at Mount Sinai in New York. Prior to that, she was the medical director of the Cardiogenic Shock Program at NYU School of Medicine. She was the former medical director of mechanical circulatory support at Newark Beth Israel.
